Mounjaro Shown to Improve Heart Health
03 August 2025
Posted by Dr John Weight Loss Pharmacy
A large global study confirmed that Mounjaro (tirzepatide) reduces the risk of heart attack, stroke, and cardiovascular-related death in people with type 2 diabetes. It's not just for weight loss—it's protecting hearts too.
More posts to explore
News
Australia Expands Access to Effective Weight-Loss Medications
3/8/2025
News
New Once-Monthly Weight Loss Injection Shows Promise
3/8/2025
News
GLP-1 Medications May Lower Risk of Dementia
3/8/2025
News
Broader Health Benefits Beyond Weight Loss
3/8/2025
News
Cardiovascular Benefits with Mounjaro
3/8/2025